PA
UTHR icon

Pinnacle Associates’s United Therapeutics UTHR Stock Holding History

Pinnacle Associates’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$460K Sell
849
-5
-0.6% -$2.82K 0.01% 716
2026
Q1 		$506K Sell
854
-151
-15% -$75.2K 0.01% 658
2025
Q4 		$490K Buy
1,005
+195
+24% +$90.8K 0.01% 656
2025
Q3 		$340K Sell
810
-50
-6% -$16.8K ﹤0.01% 719
2025
Q2 		$247K Buy
860
+50
+6% +$14.9K ﹤0.01% 785
2025
Q1 		$250K Hold
810
– – ﹤0.01% 756
2024
Q4 		$286K Buy
+810
New +$298K ﹤0.01% 729
2024
Q3 		– Sell
-910
Closed -$290K – 851
2024
Q2 		$290K Sell
910
-50
-5% -$13.2K ﹤0.01% 695
2024
Q1 		$221K Buy
+960
New +$217K ﹤0.01% 778
2018
Q1 		– Sell
-2,915
Closed -$431K – 713
2017
Q4 		$431K Sell
2,915
-1,060
-27% -$135K 0.01% 518
2017
Q3 		$466K Sell
3,975
-140
-3% -$17.9K 0.01% 503
2017
Q2 		$534K Sell
4,115
-755
-16% -$94.2K 0.01% 495
2017
Q1 		$659K Sell
4,870
-9,309
-66% -$1.41M 0.01% 460
2016
Q4 		$2.03M Sell
14,179
-670
-5% -$85.5K 0.04% 303
2016
Q3 		$1.75M Sell
14,849
-8,868
-37% -$1.07M 0.04% 317
2016
Q2 		$2.51M Sell
23,717
-18,723
-44% -$2.09M 0.05% 272
2016
Q1 		$4.73M Buy
42,440
+30
+0.1% +$3.8K 0.1% 203
2015
Q4 		$6.64M Sell
42,410
-1,435
-3% -$209K 0.14% 158
2015
Q3 		$5.75M Sell
43,845
-1,376
-3% -$221K 0.13% 171
2015
Q2 		$7.87M Sell
45,221
-3,215
-7% -$578K 0.15% 149
2015
Q1 		$8.35M Buy
+48,436
New +$7.38M 0.16% 145

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Pinnacle Associates's UTHR Position: Q2 2026 in Review

Pinnacle Associates reduced its United Therapeutics (UTHR) stake by 0.59% in Q2 2026, selling an estimated $2.82K and leaving 849 shares worth $460K. The position accounts for 0.01% of the portfolio, ranked #716.

Pinnacle Associates first reported a position in UTHR in Q1 2015 and has held it in 21 quarters since. The position peaked at $8.35M in Q1 2015. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Pinnacle Associates held 849 shares of United Therapeutics worth $460K as of Q2 2026.
  • Pinnacle Associates sold 5 United Therapeutics shares in Q2 2026, an estimated $2.82K.
  • United Therapeutics made up 0.01% of Pinnacle Associates's portfolio in Q2 2026, its #716 holding.
  • Pinnacle Associates first reported a position in United Therapeutics in Q1 2015 and has held it in 21 quarters since.
  • Pinnacle Associates's United Therapeutics position peaked at $8.35M in Q1 2015.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Pinnacle Associates's 13F filing for Q2 2026, filed 3 Aug 2026.